Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection

Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma

(2012) Elisabetta Cariani et al.   PLoS One

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative Resection

(2009) Min-Jie Ju et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma

(2009) Q. Gao et al.   CLINICAL CANCER RESEARCH

Enrichment of Human CD4+ V 24/V 11 Invariant NKT Cells in Intrahepatic Malignant Tumors

(2009) G. Bricard et al.   JOURNAL OF IMMUNOLOGY

NK and NKT cells in liver injury and fibrosis

(2008) George Notas et al.   CLINICAL IMMUNOLOGY

NKT lymphocyte polarization determined by microenvironment signaling: A role for CD8+ lymphocytes and β-glycosphingolipids

(2008) Ehud Zigmond et al.   JOURNAL OF AUTOIMMUNITY

Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues

(2008) Qiang Gao et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma

(2007) A. Sasaki et al.   EJSO

Methods for detection, isolation and culture of mouse and human invariant NKT cells

(2007) Hiroshi Watarai et al.   Nature Protocols